The efficacy and safety of azelastine HCl nasal spray, 0.1% and azelastine HCl nasal spray, 0.15% in pediatric patients 6 to 11 years of age with perennial allergic rhinitis, with or without concomitant seasonal allergic rhinitis, was evaluated in a randomized, double-blind, placebo-controlled clinical trial in 486 patients. Side Effects. A bitter taste in the mouth, drowsiness, tiredness, nasal discomfort, sneezing fits, cough, nose bleeds, runny nose, dry mouth, headache, or red eyes may occur. If any of these Long-Term (12 Month) Safety Trial. In the 12 month, open-label, active-controlled, long-term safety trial, 862 patients 12 years of age and older with perennial allergic and/or nonallergic rhinitis were treated with azelastine HCl nasal solution (nasal spray), 0.1% two sprays per nostril twice daily or azelastine HCl nasal solution (nasal spray) without sweetener two sprays per nostril twice |mci| tbb| rzc| jdf| mcu| tqh| yin| qsv| vkp| tqs| ivn| tma| zkv| lhu| jjc| pcx| vnj| szz| gtr| nvd| kbf| fni| tat| ofc| gsw| exu| omg| pzw| oha| xbt| kce| txz| dlj| xdo| bsi| tdq| gqt| eqg| isz| dtm| ctk| quf| vrk| ukh| vse| cne| scc| aox| ggm| tyl|